We report on findings from the clinical feasibility study of the ImagioTM. Breast Imaging System, which acquires two-dimensional opto-acoustic (OA) images co-registered with conventional ultrasound using a specialized duplex hand-held probe. Dual-wavelength opto-acoustic technology is used to generate parametric maps based upon total hemoglobin and its oxygen saturation in breast tissues. This may provide functional diagnostic information pertaining to tumor metabolism and microvasculature, which is complementary to morphological information obtained with conventional gray-scale ultrasound. We present co-registered opto-acoustic and ultrasonic images of malignant and benign tumors from a recent clinical feasibility study. The clinical results illustrate that the technology may have the capability to improve the efficacy of breast tumor diagnosis. In doing so, it may have the potential to reduce biopsies and to characterize cancers that were not seen well with conventional gray-scale ultrasound alone.
© (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jason Zalev ; Bryan Clingman ; Remie J. Smith ; Don Herzog ; Tom Miller, et al.
Clinical feasibility study of combined opto-acoustic and ultrasonic imaging modality providing coregistered
functional and anatomical maps of breast tumors
", Proc. SPIE 8581, Photons Plus Ultrasound: Imaging and Sensing 2013, 858103 (March 4, 2013); doi:10.1117/12.2009112; http://dx.doi.org/10.1117/12.2009112